Literature DB >> 28515470

A novel missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria and cleft palate.

Koji Kato1,2, Fuyuki Miya3,4, Ikumi Hori1, Daisuke Ieda1, Kei Ohashi1, Yutaka Negishi1, Ayako Hattori1, Nobuhiko Okamoto5, Mitsuhiro Kato6, Tatsuhiko Tsunoda3,4, Mami Yamasaki7, Yonehiro Kanemura8,9, Kenjiro Kosaki10, Shinji Saitoh1.   

Abstract

We identified a novel de novo heterozygous missense mutation in the NEDD4L gene (NM_015277: c.2617G>A; p.Glu873Lys) through whole-exome sequencing in a 3-year-old girl showing severe global developmental delay, infantile spasms, cleft palate, periventricular nodular heterotopia and polymicrogyria. Mutations in the HECT domain of NEDD4L have been reported in patients with a neurodevelopmental disorder along with similar brain malformations. All patients reported with NEDD4L HECT domain mutations showed periventricular nodular heterotopia, and most had seizures, cortex anomalies, cleft palate and syndactyly. The unique constellation of clinical features in patients with NEDD4L mutations might help clinically distinguish them from patients with other genetic mutations including FLNA, which is a well-known causative gene of periventricular nodular heterotopia. Although mutations in the HECT domain of NEDD4L that lead to AKT-mTOR pathway deregulation in forced expression system were reported, our western blot analysis did not show an increased level of AKT-mTOR activity in lymphoblastoid cell lines (LCLs) derived from the patient. In contrast to the forced overexpression system, AKT-mTOR pathway deregulation in LCLs derived from our patient seems to be subtle.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28515470     DOI: 10.1038/jhg.2017.53

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  11 in total

1.  PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.

Authors:  Laura A Jansen; Ghayda M Mirzaa; Gisele E Ishak; Brian J O'Roak; Joseph B Hiatt; William H Roden; Sonya A Gunter; Susan L Christian; Sarah Collins; Carissa Adams; Jean-Baptiste Rivière; Judith St-Onge; Jeffrey G Ojemann; Jay Shendure; Robert F Hevner; William B Dobyns
Journal:  Brain       Date:  2015-02-25       Impact factor: 13.501

Review 2.  Malformations of cortical development: clinical features and genetic causes.

Authors:  Renzo Guerrini; William B Dobyns
Journal:  Lancet Neurol       Date:  2014-06-02       Impact factor: 44.182

3.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

4.  Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.

Authors:  Ikumi Hori; Fuyuki Miya; Kei Ohashi; Yutaka Negishi; Ayako Hattori; Naoki Ando; Nobuhiko Okamoto; Mitsuhiro Kato; Tatsuhiko Tsunoda; Mami Yamasaki; Yonehiro Kanemura; Kenjiro Kosaki; Shinji Saitoh
Journal:  Am J Med Genet A       Date:  2016-04-13       Impact factor: 2.802

Review 5.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

Review 6.  A developmental and genetic classification for malformations of cortical development: update 2012.

Authors:  A James Barkovich; Renzo Guerrini; Ruben I Kuzniecky; Graeme D Jackson; William B Dobyns
Journal:  Brain       Date:  2012-03-16       Impact factor: 13.501

7.  47 patients with FLNA associated periventricular nodular heterotopia.

Authors:  Max Lange; Burkhard Kasper; Axel Bohring; Frank Rutsch; Gerhard Kluger; Sabine Hoffjan; Stephanie Spranger; Anne Behnecke; Andreas Ferbert; Andreas Hahn; Barbara Oehl-Jaschkowitz; Luitgard Graul-Neumann; Katharina Diepold; Isolde Schreyer; Matthias K Bernhard; Franziska Mueller; Ulrike Siebers-Renelt; Ana Beleza-Meireles; Goekhan Uyanik; Sandra Janssens; Eugen Boltshauser; Juergen Winkler; Gerhard Schuierer; Ute Hehr
Journal:  Orphanet J Rare Dis       Date:  2015-10-15       Impact factor: 4.123

8.  A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.

Authors:  Yutaka Negishi; Fuyuki Miya; Ayako Hattori; Yoshikazu Johmura; Motoo Nakagawa; Naoki Ando; Ikumi Hori; Takao Togawa; Kohei Aoyama; Kei Ohashi; Shinobu Fukumura; Seiji Mizuno; Ayako Umemura; Yoko Kishimoto; Nobuhiko Okamoto; Mitsuhiro Kato; Tatsuhiko Tsunoda; Mami Yamasaki; Yonehiro Kanemura; Kenjiro Kosaki; Makoto Nakanishi; Shinji Saitoh
Journal:  BMC Med Genet       Date:  2017-01-13       Impact factor: 2.103

9.  Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study.

Authors:  Ghayda M Mirzaa; Valerio Conti; Andrew E Timms; Christopher D Smyser; Sarah Ahmed; Melissa Carter; Sarah Barnett; Robert B Hufnagel; Amy Goldstein; Yoko Narumi-Kishimoto; Carissa Olds; Sarah Collins; Kathreen Johnston; Jean-François Deleuze; Patrick Nitschké; Kathryn Friend; Catharine Harris; Allison Goetsch; Beth Martin; Evan August Boyle; Elena Parrini; Davide Mei; Lorenzo Tattini; Anne Slavotinek; Ed Blair; Christopher Barnett; Jay Shendure; Jamel Chelly; William B Dobyns; Renzo Guerrini
Journal:  Lancet Neurol       Date:  2015-10-29       Impact factor: 44.182

10.  Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.

Authors:  Loïc Broix; Hélène Jagline; Ekaterina Ivanova; Stéphane Schmucker; Nathalie Drouot; Jill Clayton-Smith; Alistair T Pagnamenta; Kay A Metcalfe; Bertrand Isidor; Ulrike Walther Louvier; Annapurna Poduri; Jenny C Taylor; Peggy Tilly; Karine Poirier; Yoann Saillour; Nicolas Lebrun; Tristan Stemmelen; Gabrielle Rudolf; Giuseppe Muraca; Benjamin Saintpierre; Adrienne Elmorjani; Martin Moïse; Nathalie Bednarek Weirauch; Renzo Guerrini; Anne Boland; Robert Olaso; Cecile Masson; Ratna Tripathy; David Keays; Cherif Beldjord; Laurent Nguyen; Juliette Godin; Usha Kini; Patrick Nischké; Jean-François Deleuze; Nadia Bahi-Buisson; Izabela Sumara; Maria-Victoria Hinckelmann; Jamel Chelly
Journal:  Nat Genet       Date:  2016-10-03       Impact factor: 38.330

View more
  6 in total

1.  Application of Chromosome Microarray Analysis in the Investigation of Developmental Disabilities and Congenital Anomalies: Single Center Experience and Review of NRXN3 and NEDD4L Deletions.

Authors:  Alper Han Çebi; Şule Altıner
Journal:  Mol Syndromol       Date:  2020-10-05

Review 2.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

3.  Familial NEDD4L variant in periventricular nodular heterotopia and in a fetus with hypokinesia and flexion contractures.

Authors:  Miriam Elbracht; Florian Kraft; Matthias Begemann; Petra Holschbach; Michael Mull; Ildiko M Kabat; Britta Müller; Martin Häusler; Ingo Kurth; Ute Hehr
Journal:  Mol Genet Genomic Med       Date:  2018-11-04       Impact factor: 2.183

4.  Rbfox1 up-regulation impairs BDNF-dependent hippocampal LTP by dysregulating TrkB isoform expression levels.

Authors:  Francesco Tomassoni-Ardori; Gianluca Fulgenzi; Jodi Becker; Colleen Barrick; Mary Ellen Palko; Skyler Kuhn; Vishal Koparde; Maggie Cam; Sudhirkumar Yanpallewar; Shalini Oberdoerffer; Lino Tessarollo
Journal:  Elife       Date:  2019-08-20       Impact factor: 8.140

5.  RNF220 is an E3 ubiquitin ligase for AMPA receptors to regulate synaptic transmission.

Authors:  Pengcheng Ma; Li Pear Wan; Yuwei Li; Chun-Hui He; Ning-Ning Song; Shiping Zhao; Huishan Wang; Yu-Qiang Ding; Bingyu Mao; Nengyin Sheng
Journal:  Sci Adv       Date:  2022-09-30       Impact factor: 14.957

6.  Infantile spasms-linked Nedd4-2 mediates hippocampal plasticity and learning via cofilin signaling.

Authors:  Kwan Young Lee; Jiuhe Zhu; Cathryn A Cutia; Catherine A Christian-Hinman; Justin S Rhodes; Nien-Pei Tsai
Journal:  EMBO Rep       Date:  2021-08-03       Impact factor: 9.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.